AbbVie, U. Chicago ally in cancer research
In a five-year collaboration, AbbVie Inc. is teaming up with the University of Chicago in cancer research and drug discovery. (Apr.)
Tech Transfer Deals, May 2016
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Tech Transfer Deals column provides a monthly update on technology transfer deals, reporting licensing agreements between companies and universities or other research institutions within the In Vitro Diagnostics, Medical Devices, and Pharmaceuticals sectors. This month’s column covers deals announced March through April 2016.
More from Deals
More from Business
• By
In this week's episode: a preview of major ASCO readouts; Roivant stays patient in deals; Lilly diversifies pain pipeline with SiteOne acquisition; Nucala gets US COPD nod; and women in Indian pharma.
• By
In a study intended to show similar benefit in western patients, PD-1/VEGF-targeting ivonescimab met a progression-free survival endpoint, but missed on OS.
• By
One Phase III trial hits but a second study misses by a mile.